Pappas Capital, LLC insider trades: CoLucid Pharmaceuticals (CLCD) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Pappas Capital, LLC reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 11, 2015 | CLCD | ↑ Buy | 282,440 | $10.00 | $2.8M | By A. M. Pappas Life Science Ventures II | May 12, 2015 (1d) |
| May 11, 2015 | CLCD | ↑ Buy | 17,560 | $10.00 | $176K | By PV III CEO Fund, L.P. | May 12, 2015 (1d) |
| Sep 13, 2005 | PANC | ↓ Sell | 104,201 | $10.52 | $1.1M | Indirect | Sep 13, 2005 (0d) |
| Sep 9, 2005 | PANC | ↓ Sell | 108,848 | $10.75 | $1.2M | Direct | Sep 13, 2005 (4d) |
| Aug 9, 2005 | VITX | ↓ Sell | 90,918 | $7.55 | $686K | Direct | Aug 9, 2005 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Pappas Capital, LLC's insider trades
Pappas Capital, LLC is a 10% owner of CoLucid Pharmaceuticals (CLCD). Since Aug 9, 2005, it has reported 2 open-market purchases worth $3.0M and 3 sales worth $3.0M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (5 filings), conversions (3 filings), grants and awards (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CLCD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.